Skip to main content
Matthew Abramowitz, MD, Radiation Oncology, Miami, FL

Matthew C Abramowitz MD

Central Nervous System Cancer, Head & Neck, Urologic Cancer


Associate Professor, Radiation Oncology, University of Miami School of Medicine

Join to View Full Profile
  • 1475 Nw 12th AveSuite 1500Miami, FL 33136

  • Phone+1 305-243-4200

  • Fax+1 305-243-4363

Dr. Abramowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Temple University Hospital/Fox Chase Cancer Center
    Temple University Hospital/Fox Chase Cancer CenterResidency, Radiation Oncology, 2004 - 2008
  • Crozer-Chester Medical Center
    Crozer-Chester Medical CenterInternship, Transitional Year, 2003 - 2004
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2008 - 2026
  • PA State Medical License
    PA State Medical License 2003 - 2014
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Cutting-Edge Precision: Ushering in a New Era of Incision-Free Functional Radiosurgery
    Cutting-Edge Precision: Ushering in a New Era of Incision-Free Functional RadiosurgerySeptember 30th, 2025
  • Precision and Innovation: Sylvester Comprehensive Cancer Center at ASTRO 2025
    Precision and Innovation: Sylvester Comprehensive Cancer Center at ASTRO 2025September 30th, 2025
  • New Prostate Cancer Test Pinpoints Disease Better Than PSA Option, Study Finds
    New Prostate Cancer Test Pinpoints Disease Better Than PSA Option, Study FindsMay 1st, 2025
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: